Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q3 2025 ▲▼ | Q4 2025 ▲▼ | Change ▲▼ | Q3 2025 ▲▼ | Q4 2025 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| CG Oncology, Inc.(CGON) | 2,221,474 | 2,221,474 | 0 | $89.48M | $92.24M | 27.88% | +$2.75M |
| RAPT Therapeutics, Inc. | 1,562,500 | 1,562,500 | 0 | $40.30M | $52.92M | 16.00% | +$12.63M |
| Alumis Inc. | 4,247,670 | 4,247,670 | 0 | $16.95M | $41.46M | 12.53% | +$24.51M |
| Centessa Pharmaceuticals plcADS | 1,314,019 | 1,364,019 | +50,000 | $31.86M | $34.11M | 10.31% | +$2.25M |
| Verastem, Inc.(VSTM) | 2,615,120 | 3,135,120 | +520,000 | $23.09M | $24.20M | 7.32% | +$1.11M |
| Denali Therapeutics Inc.(DNLI) | 1,000,000 | 1,000,000 | 0 | $14.52M | $16.51M | 4.99% | +$1.99M |
| Natera, Inc.(NTRA) | 0 | 67,356 | +67,356 | $0 | $15.43M | 4.66% | +$15.43M |
| Agios Pharmaceuticals, Inc.(AGIO) | 0 | 530,000 | +530,000 | $0 | $14.43M | 4.36% | +$14.43M |
| Kymera Therapeutics, Inc.(KYMR) | 146,332 | 146,332 | 0 | $8.28M | $11.39M | 3.44% | +$3.10M |
| Atai Beckley N.V.SHS | 0 | 2,750,000 | +2,750,000 | $0 | $11.25M | 3.40% | +$11.25M |
| Corvus Pharmaceuticals, Inc.(CRVS) | 1,731,233 | 1,381,233 | -350,000 | $12.76M | $10.64M | 3.21% | -$2.12M |
| Hinge Health, Inc.CL A(HNGE) | 135,000 | 135,000 | 0 | $6.63M | $6.27M | 1.90% | -$355.1K |
| Akero Therapeutics, Inc. | 244,900 | 0 | -244,900 | $11.63M | $0 | — | -$11.63M |
| Avidity Biosciences, Inc. | 40,000 | 0 | -40,000 | $1.74M | $0 | — | -$1.74M |
| CASI Pharmaceuticals, Inc.(CASIF) | 979,956 | 0 | -979,956 | $1.63M | $0 | — | -$1.63M |